mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.035 |
0.5 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.037 |
0.5 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.5 |